Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Smitesh Shah (DIN: 00326182) as Non- Executive Director of the company w.e.f. August 23, 2025.
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has appointed Mr. Smitesh Shah (DIN: 00326182) as an Additional Director in the Promoter Non-Executive Non-Independent category, effective August 23, 2025. Mr. Shah, aged 65, is a B.Sc. graduate with 45 years of experience in the pharmaceutical industry and holds directorships in 6 other companies. The appointment was made on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval at the upcoming 40th Annual General Meeting. He will hold office up to the next AGM or three months from the date of appointment, whichever is earlier. Notably, Mr. Smitesh Shah is the uncle of Shri Ketan Shah, the current Chairman and Managing Director of the company.
This is a routine board-level change that strengthens promoter family representation on the board. It is unlikely to have a material impact on the stock price, though it signals continued promoter involvement in the company's governance.